European Healthtech startup funding raised during H1 2012.
In H1 2012, 35 European Healthtech companies raised a combined €188M across 36 funding rounds, down 38.7% versus H1 2011. UK led by capital raised, and Italian Angels for Growth was the most active investor. Data as of 7 Aug 2026.
| Jan 2012 |
| €8.4M |
| Pharnext | Other | Feb 2012 | €8.0M |
| BONESUPPORT | Early VC | Jun 2012 | €7.8M |
| Gamida Cell | Series D+ | May 2012 | €7.6M |
| Numares | Series B | Feb 2012 | €7.2M |
| Enterome | Series A | Mar 2012 | €5.0M |
| Simplee | Series A | May 2012 | €4.5M |
| CartiHeal | Early VC | Feb 2012 | €3.8M |
| Spinelab | Series C | May 2012 | €3.7M |
| Abingdon Health | Early VC | Mar 2012 | €3.6M |
| Aleva Neurotherapeutics | Series B | Apr 2012 | €3.3M |
| Alize Pharma | Seed | Jun 2012 | €3.3M |
